Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus

Neurology

Volumn 51, Issue 2, 1998, Pages 535-540

  Donders, R C J M ^a   Kappelle, L J ^b   Derksen, R H W M ^b   Algra, A ^b   Horbach, D A ^b   De Grootj, Ph G ^b   Van Gijn, G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; BLINDNESS; FEMALE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION RETINOPATHY; INCIDENCE; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VISUAL DISORDER;

EID: 0031783857     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.535     Document Type: Article

References (34)

1. Hurwitz BJ, Heyman A, Wilkinson WE, Haynes CS, Utley CM. Comparison of amaurosis fugax and transient cerebral ischemia: a prospective clinical and arteriographic study. Ann Neurol 1985;18:698-704.
2. Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848-853.
3. Poole CJM, Ross Russell RW. Mortality and stroke after amaurosis fugax. J Neurol Neurosurg Psychiatry 1985;48:902-905.
4. Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry 1991;54:793-802.
5. Fisher CM. Transient monocular blindness associated with hemiplegia. Arch Ophthalmol 1952;47:167-203.
6. Wray SH. Visual aspects of extracranial internal carotid artery disease. In: Bernstein EF, ed. Amaurosis fugax. New York: Springer-Verlag, 1988:72-80.
7. Bruno A, Corbett JJ, Biller J, Adams HP, Quails C. Transient monocular visual loss patterns and associated vascular abnormalities. Stroke 1990;21:34-39.
8. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112:682-698.
9. Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med 1991;325:870-873.
10. Asherson RA, Khamashta MA, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-399.
11. Levine SR, Brey RL, Joseph CLM, Havstad S, on behalf of the Antiphospholipid Antibodies in Stroke Study Group. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992; 23(suppl 1):I29-I32.
12. McHugh NJ, Maymo J, Skinner RP, James I, Maddison PJ. Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. Ann Rheum Dis 1988;47:110-115.
13. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994;83:372-377.
14. Grattan CEH, Burton JL, Boon AP. Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies. Br J Dermatol 1989;120:441-447.
15. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332: 993-997.
16. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47-51.
17. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23: 189-193.
18. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993;43:2069-2073.
19. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-344.
20. Champion RH. Cutaneous reactions to cold. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL, eds. Textbook of dermatology. 4th ed. Oxford: Blackwell Scientific, 1990:627-631.
21. Copeman PWM. Livedo reticularis: signs in the skin of disturbance of blood viscosity and of blood flow. Br J Dermatol 1975;93:519-529.
22. Lockshin MD. Answers to the antiphospholipid-antibody syndrome? N Engl J Med 1995;332:1025-1027.
23. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965;77:180-185.
24. Stockhammer G, Felber SR, Zeiger B, et al. Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 1993;24:685-690.
25. Zeiger B, Sepp N, Stockhammer G, et al. Sneddon's syndrome: a long-term follow-up of 21 patients. Arch Dermatol 1993;129: 437-447.
26. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
27. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987;123:596-600.
28. Horbach DA, van Oort E, Donders RCJM, Derksen RHWM, de Groot PhG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost 1996;76:916-924.
29. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640.
30. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):19-28.
31. Fijnheer R, Horbach DA, Donders RCJM, et al. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost 1996;76:514-517.
32. Andersen CU, Marquardsen J, Mikkelsen B, Nehen JH, Pedersen KK, Vesterlund T. Amaurosis fugax in a Danish community: a prospective study. Stroke 1988;19:196-199.
33. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994; 44:S17-S23.
34. Donders RCJM, Kappelle LJ, Algra A, et al. Subtypes of transient monocular blindness and subsequent risk of vascular complications. Cerebrovasc Dis 1996;6:241-247.